Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to
evaluate the efficacy and safety of Dp-R206 and Bonviva for 16 weeks once a month on the
improvement of vitamin D in postmenopausal women with osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Alvogen Korea
Treatments:
Cholecalciferol Ibandronic Acid Vitamin D Vitamins